Psychopharmacology and Psychiatry Updates

265 Episodes

1. Association Between Mood Disorders and COVID-19

   Published: 6/16/2022
2. Antidepressants and Naltrexone for Stimulant Use Disorder

   Published: 6/11/2022
3. CANMAT Task Force Recommendations for the Use of Ketamine

   Published: 6/6/2022
4. Stimulant Replacement Therapies for Methamphetamine and Amphetamine Use Disorder

   Published: 6/1/2022
5. Premenstrual Mood Syndromes

   Published: 5/27/2022
6. Stimulant Use Disorder: Diagnosis and Assessment

   Published: 5/22/2022
7. Zuranolone for Postpartum Depression

   Published: 5/17/2022
8. Long-Term Treatment of First Episode of Psychosis

   Published: 5/12/2022
9. The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia

   Published: 5/7/2022
10. Health Issues in First Episode of Psychosis

    Published: 5/2/2022
11. Psychopharmacology for Treatment-Resistant Early Psychosis

    Published: 4/27/2022
12. Assessing and Treating Adult ADHD

    Published: 4/22/2022
13. Medications for Binge Eating Disorder

    Published: 4/17/2022
14. Antipsychotics for First Episodes of Psychosis

    Published: 4/12/2022
15. Effects on Suicidal Risk With Different Medications

    Published: 4/7/2022
16. Risks of Using Cannabinoids

    Published: 4/2/2022
17. Lithium: How to Manage Dosage

    Published: 3/28/2022
18. CBD as a Medication

    Published: 3/23/2022
19. SSRIs and Suicidality

    Published: 3/18/2022
20. Cannabis and Cognition

    Published: 3/13/2022